| Authors: |
Naik MG; Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charite University Medicine Berlin, Germany. Electronic address: marcel.naik@charite.de., Jürgensen JS; Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charite University Medicine Berlin, Germany; Division of Nephrology, EBC University Berlin and Klinikum, Stuttgart, Germany., Arns W; Transplant Centre Cologne, Cologne General Hospital, Cologne, Germany., Basic E; Pfizer Pharma GmbH, Berlin, Germany., Budde K; Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charite University Medicine Berlin, Germany., Eitner F; Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany., Fischereder M; Department of Medicine IV, University Hospital LMU, Munich, Germany., Goßmann J; Division of Nephrology, Transplant Care Centre Frankfurt, Frankfurt, Germany., Heller KM; Division of Nephrology, Department of Medicine, University of Erlangen, Erlangen, Germany., Heyne N; Division of Nephrology, Universitätsklinikum Tübingen, Tübingen, Germany., Morath C; Division of Nephrology, University of Heidelberg, Heidelberg, Germany., Riester U; Pfizer Pharma GmbH, Berlin, Germany., Diekmann F; Department of Nephrology and Kidney Transplantation, Hospital Clinic, Barcelona, Spain., Gwinner W; Division of Nephrology, Hannover Medical School, Hannover, Germany. |
